0000899243-19-030008.txt : 20191223
0000899243-19-030008.hdr.sgml : 20191223
20191223191105
ACCESSION NUMBER: 0000899243-19-030008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191219
FILED AS OF DATE: 20191223
DATE AS OF CHANGE: 20191223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mulholland Michael D.
CENTRAL INDEX KEY: 0001257911
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49908
FILM NUMBER: 191307712
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER NAME:
FORMER CONFORMED NAME: MULHOLLAND MICHAEL D
DATE OF NAME CHANGE: 20030801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoDyn Inc.
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: CYTODYN INC
DATE OF NAME CHANGE: 20031114
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-19
0
0001175680
CytoDyn Inc.
CYDY
0001257911
Mulholland Michael D.
1111 MAIN STREET, SUITE 660
VANCOUVER
WA
98660
0
1
0
0
See Remarks
Stock Option (right to buy)
0.63
2019-12-19
4
A
0
700000
0.00
A
2029-12-19
Common Stock
700000
700000
D
One-half of the options vest immediately upon grant and one-half of the options will vest upon the achievement of certain additional strategic milestones specified in the award agreement.
Senior Vice President of Finance
/s/ Michael D. Mulholland, as attorney-in-fact
2019-12-23